Company intelligence / Profile preview

Compass Oncology

Portland, Oregon, USAcompassoncology.com ↗

Ownership: Private
Employees: ~260
Development stage: Commercial

Overview

Compass Oncology provides comprehensive outpatient oncology care—including medical oncology/hematology services and access to leading-edge clinical trials—primarily serving patients in Oregon and Southwest Washington. It does not develop its own therapeutics but participates in research through partnerships with organizations like Sarah Cannon Research Institute.

Therapeutic areas: OncologyHematology
Modalities: Small moleculeMonoclonal antibodyRadiation therapyTargeted therapyHormone therapy
Industry: Non-Academic Healthcare

Drug pipeline

2 assets

bendamustine

Commercial

Indications: Chronic lymphocytic leukemia

1 more asset in the full pipeline.

Request access →

Partnerships

Sarah Cannon Research InstituteThe US Oncology NetworkMcKesson Corporation

Beyond the preview

Go deeper on Compass Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compass Oncology.

Explore the full profile